Розділ 2)
Cuenca-Estrella M., Gomez-Lopez A., Mellado E., Garcia-Effron, Rodrigues-Tudela
J.L. In vitro activities of ravuconasole and four other antifungal agents
against fluconazole-resisnance or- susceptible clinical yeasts isolates //
Antimicrob. Agents and Chemother.-2004.-№48.-P.3107-3111.
Dalhoff A. In vitro activites of quinolones // Exp. Opin Invest Drugs.-1999.-
Vol. 8(2).- P.123-137.
Davison J. Genetic exchange between bacteria in the environment // Plasmid.-
1999.-Vol.42.-P.73-91.
Petropoulou A., Kavatzas N., Etratigos A.D., Adamis T., Baziaka F. Early
Cutaneous Alterations in Experimental Sepsis by Pseudomonas aeruginosa //
Dermatology.?2004.?Vol. 209.– P.111-116.
Eisch J.J., Gopal H., Kuo Ch.-T. Studies on nonpyridinoid azaaromatik systems.
Synthesis and tautomeric character of cyclopenta[c]quinoline
benzo[c][2]pyridine // J. Organic Chemistry.-1978.-Vol.43.-№11.-P.2190-2196.
Poizel L., Heritier C.,.Polun V, Nordmann P. Emergence of Oxacillinase Mediated
Resistance to imipinem in Klebsiella pneumoniae // Antimicrob. Agents and
Chemother.–2004.?Vol.48.–P.15-22.
Emmerson M. Surveillance strategies for nosocomial infections // Cur Opin.
Infect.- 1995.-Vol.8.- P.272-274.
Lautenbach E., Strom B.L., Bilker W.B., Patel J.B., Edelstelstein P.H., Fishman
N.O. Epidemiological investigation of fluoroquinolone resistance in infections
due to extended- spectrum в-lactamase-producing Escherichia coli and Klebsiella
pneumoniae / / Clin.Infect.Dis.-2001.-№33.-P.1288-1294.
Paterson D.L., Mulazimoglu L., Casellas J.M., Ko W.C., Goossens H., Von
Gottberg S., Mohapatra S., Trencholme G.M., Klugman K.P., McCormak J.G., Yu
V.L. Epidemiology of ciprofloxacin resistance and its relationship to
extended-spectrum в-lactamase production in Klebsiella pneumonia isolates
causing bacteremia // Clin.Infect.Dis.-2000.-№30.-P.473-478.
Sartor C., Edwards J.R., Gaynes R.P., Culver D.H. Evolution of hospital
participation in the National Nosocomial Infections Surveillance System, 1986
to 1993 // Amer. J. Infect. Control.- 1995.- Vol. 223.- P. 364-368.
Fedchuk A.S., Loritsky V.P., Gridina T.L. Antiinfluenza and antitherpetic
activity of decametoxin // Antiviral Reserch. – 2003. – Vol. 57. – P. 137.
Claude Puiol Michael A., Pfaller A., David R., Soll S. Fluctosine Resistance is
Restricted to a Single Genetic Clade of Candida albiсans // Antimicrob. Agents
and Chemother.? 2004.?Vol.48.–P.262-266.
Frank U., Sterk Y., Daschner F. Incidence and Epidemiology of Nosocomial
Infections (NI) in HIV-Infected Patients in a German University Hospital //
Proceedings of the 35th ICCAC Conference.-1995.- P.135-137.
Galvez-Vargas R., Bueno-Cavanillas A., Garcia-Martin M. Epidemiology, Therapy
and Costs of Nosocomial Infection // Pharmacoeconomics.-1995.- Vol.7 (2).-
P.128-140.
Gazan J., Xercavins M., Rodrigueenz-Carballeira M. Emergence and dissemination
of quinolone-resistant Escherichia coli in the community // Antimicrob. Agents
and Chemother.-1999.-Vol.43.- P.2736-2741.
Gastmeier P., Sohr D., Schumacher M. To What Extent can Antibiotic use be
Reduced by Preventing Nosocomial Infections // Proceedings of the 8th ECCMID
Congress.- 1997.- P.111-113.
Gill M.J., Brenwald N.P., Wise R. Identification of an efflux pumpgene pmrA
assotiated with fluoroquinolone resistance in Streptococcus pneumoniae //
Antimicrob. Agents and Chemother.-1999.-Vol.43.-P.187-189.
Grabik I., Paliy V.G. Sensitivity of antibiotic-resistant strains of
microorganisms to antiseptic compositions including dekametoxine //
International Weigl conference Microorganisms in patogenesis and their drug
resistance.? Lviv, 2003.– P.58.
Gupta A.K., Kohli Y. Evaluation of in vitro Resistance in Patients with
onychomycosis who Fail Antifungal Therapy // Dermatology.?2003.?Vol. 207.–
P.375-380.
Hanssen A.M., Kjeldsen G., Ericson J.U.S. Coagulase Negative Staphylococci:
Evidence of Horizontal Gene Transfer? // Antimicrob. Agents and Chemother.?
2004.? Vol.48.–P.285-296.
Haddadin A.S., Fappiano S.A. Methicillin resistant Staphylococcus aureus (MRSA)
in the intensive care unit // Postgr. Med.J.?2002.? Vol.78(921).? P. 385-392.
In vitro and in vivo antibacterial activities of DK-507R, a novel
fluoroquinolone / Otani T., Tanaka M., Ito E., Kurosaka Y., Murakami Y.,
Onodera K. et al.// Antimicrob.Agents and Chemother.-2003.-№47.-P.3750-3759.
Itokasu G.S., Quinn J.P., Bell-Dixon C., Kahan F.M., Weinstein R.A.
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered
from patients in intensive care units evaluation of a national postmarketing
surveillance program // Clin.Infect.Dis.-1996.-№23.-P.779-784.
Jacoby G.A., Han P. Detection of extended-spectrum в-lactamases in clinical
isolates of Klebsiella pneumoniae and Escherichia coli // J.
Clin.Microbiol.-1996.-№34.-P.908-911.
Jacoby G.A., Chow N., Waites K.B. Prevalence of Plasmid-Mediated Quinolone
Resistance // Antimicrob. Agents and Chemother.-2003.-№2.-P.559-562.
Jarvis W.R. Selected aspects of the socioeconomic impact of nosocomial
infections: morbidity, mortality, cost and prevention // Infect. Control Hosp.
Epidemiol.-1996.-Vol.17.-P.552-557.
Juan W.R., Yang L.C., Hong H.S. Acute Generalized Exanthematous Pustulosis
Induced by Topical Lindane // Dermatology.?2004.?Vol.209.–P. 239-240.
Kallen A., Driscoll T., Thornton S. Increase in community-acquired
methicillin-resistant Staphylococcus aureus involved in a hospital outbreak //
J. Clin. Microbiol.-1999.-Vol. 37.- P.2858-2862.
Kovalchuk V.P., Paliy I.G. Prophylaxis and diagnosis of infections
compli
- Київ+380960830922